Drug names
Abbreviations
FAQ
About us
Contact us
Press news
Home
Formulary
Store
SDSD
Document library
Bulletin board
Latest additions
News
Testmonials
English
German
Prelims
Preface
How PCF is constructed
Summary of main changes in PCF4
Monographs not in PCF4 but available elsewhere
Getting the most out of PCF
The use of drugs beyond (off-label) and without (unlicensed) Marketing Authorization
Part 1 Drug Monographs
(
Expand All
|
Collapse All
)
1 Gastro-intestinal system
Antacids
Compound Alginate Products
Simeticone
Antimuscarinics
Glycopyrronium
Hyoscine butylbromide
Hyoscine hydrobromide
Propantheline
Prokinetics
H
2
-receptor antagonists
Misoprostol
Proton pump inhibitors
Loperamide
Laxatives
Ispaghula (Psyllium) husk
Stimulant laxatives
Docusate sodium
Lactulose
Macrogols (polyethylene glycols)
Magnesium salts
Rectal products
Products for haemorrhoids
Pancreatin
Quick practice guides
Management of death rattle (noisy respiratory secretions)
Opioid-induced constipation
Bowel management in paraplegia and tetraplegia
2
Cardiovascular system
Furosemide
Spironolactone
Systemic local anaesthetics
*Flecainide
*Clonidine
Glyceryl trinitrate
Nifedipine
Low molecular weight heparin (LMWH)
Dalteparin
Enoxaparin
Etamsylate
Antifibrinolytic drugs
3 Respiratory system
Bronchodilators
Ipratropium bromide
Tiotropium
Salbutamol
Inhaled long-acting β
2
agonists (LABAs)
Theophylline
Inhaled corticosteroids
Oxygen
Drugs for cough
Mucolytics
Antitussives
4 Central nervous system
Psychotropics
Benzodiazepines
Diazepam
Midazolam
Clonazepam
Lorazepam
Melatonin
Antipsychotics
Haloperidol
Prochlorperazine
Levomepromazine
Olanzapine
Risperidone
Quetiapine
Antidepressants
Amitriptyline
Nortriptyline
Selective serotonin re-uptake inhibitors
*Venlafaxine
Duloxetine
Mirtazapine
Trazodone
* Psychostimulants
*Methylphenidate
*Modafinil
*Cannabinoids
*Cannabis sativa extract
*Nabilone
Anti-emetics
Metoclopramide
Domperidone
Antihistaminic antimuscarinic anti-emetics
5HT
3
antagonists
Anti-epileptics
Anti-epileptic pre-synaptic calcium-channel blockers
Gabapentin
Pregabalin
Anti-epileptic sodium-channel blockers (membrane stabilizers)
Carbamazepine
Oxcarbazepine
Valproate
Levetiracetam
Phenobarbital
Orphenadrine
Quick practice guides
Depression
Psychostimulants in depressed patients with a short prognosis
Management of nausea and vomiting
5 Analgesics
Principles of use of analgesics
Adjuvant analgesics
Paracetamol
Nefopam
Non-steroidal anti-inflammatory drugs (NSAIDs)
Celecoxib
Diclofenac sodium
Flurbiprofen
Ibuprofen
*Ketorolac trometamol
Naproxen
Nabumetone
Weak opioids
Codeine phosphate
Dihydrocodeine
Dextropropoxyphene
Tramadol
Strong opioids
Morphine
Diamorphine
*Alfentanil
Buprenorphine
Fentanyl
Fentanyl (transmucosal)
Hydromorphone
*Methadone
Oxycodone
Opioid antagonists
Naloxone
Naltrexone
Quick practice guides
Management of procedure-related pain
Use of transdermal buprenorphine
Use of transdermal fentanyl patches
Use of methadone for cancer pain
6 Infections
Antibacterials in palliative care
Oropharyngeal candidosis
Metronidazole
Urinary tract infections
Cellulitis in a lymphoedematous limb
Clostridium difficile infection
Helicobacter pylori gastritis
Quick practice guide
Cellulitis in Lymphoedema
7 Endocrine system and immunomodulation
Bisphosphonates
Zoledronic acid
Ibandronic acid
Systemic corticosteroids
Demeclocycline
Desmopressin
Drugs for diabetes mellitus
*Octreotide
Progestogens
Danazol
*Thalidomide
8 Urinary tract disorders
Tamsulosin
Oxybutynin
Methenamine hippurate
Cranberry juice
Catheter patency solutions
Discoloured urine
9 Nutrition and blood
Anaemia
Ferrous sulphate
Ascorbic acid (vitamin C)
Phytomenadione (vitamin K
1
)
Potassium
Magnesium
Zinc
10 Musculoskeletal and joint diseases
Depot corticosteroid injections
Rubefacients and other topical products
Skeletal muscle relaxants
Baclofen
Dantrolene sodium
Tizanidine
11 Ear, nose and oropharynx
Mouthwashes
Artificial saliva and topical saliva stimulants
Pilocarpine
Drugs for oral inflammation and ulceration
Cerumenolytics
12 Skin
Emollients
Topical antipruritics
Barrier products
13 Anaesthesia
*Ketamine
*Propofol
Part 2 General Topics
14
Guidance about prescribing in palliative care
15
Opioid dose conversion ratios
16
Drug treatment in the imminently dying
17
Pre-emptive prescribing in the community
18
Management of postoperative pain in opioid-dependent patients
19
Analgesic drugs and fitness to drive
20
Continuous subcutaneous infusions
21
Spinal analgesia
22
Drug administration to patients with swallowing difficulties or enteral feeding tubes
23
Nebulized drugs
24
Prolongation of the QT interval in palliative care
25
Cytochrome P450
26
Drug-induced movement disorders
27
Anaphylaxis
28
Oral nutritional supplements
Appendicies
A1
Appendix 1: Obtaining Unlicensed Products
A2
Appendix 2: Taking controlled and prescription drugs to other countries
A3
Appendix 3: Compatibility charts
Quick Practice Guides
Management of death rattle (noisy respiratory secretions)
Opioid-induced constipation
Bowel management in paraplegia and tetraplegia
Depression
Psychostimulants in depressed patients with a short prognosis
Management of nausea and vomiting
Management of procedure-related pain
Use of transdermal buprenorphine
Use of transdermal fentanyl patches
Use of methadone for cancer pain
Cellulitis in Lymphoedema
Setting up a McKinley T34 syringe pump for CSCI
Setting up a Graseby MS16A or MS26 syringe driver for CSCI
Administration of drugs by enteral feeding tube